Clinical trial
A Study of Cidofovir in HIV-Infected Children With Cytomegalovirus (CMV) Disease
NCT00000881 · National Institute of Allergy and Infectious Diseases (NIAID), NIH · Withdrawn
Key facts
| NCT number | NCT00000881 |
|---|---|
| Title | A Study of Cidofovir in HIV-Infected Children With Cytomegalovirus (CMV) Disease |
| Official title | A Phase I/II Study of Cidofovir for HIV-Infected Children With Invasive CMV (Cytomegalovirus) Disease |
| Lead sponsor | National Institute of Allergy and Infectious Diseases (NIAID), NIH |
| Status | Withdrawn |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Cytomegalovirus Infections, Cytomegalovirus Retinitis, HIV Infections |
| Intervention type | Drug |
| Interventions | Cidofovir, Probenecid |
| Enrollment | 0 |
| First posted | Aug 31, 2001 |
| Last update posted | Oct 29, 2021 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: